A clinical study of OvcaVax for ovarian cancer.
Latest Information Update: 20 Oct 2017
At a glance
- Drugs 4T1 IL-2 GM CSF vaccine (Primary)
- Indications Ovarian cancer
- Focus Adverse reactions
- 20 Oct 2017 New trial record
Latest Information Update: 20 Oct 2017